All News

This debate posed the question: "If no elective inductions before 39 weeks, why not induce everyone at 39 weeks?" The debate looked at the feasibility of induction as well as the safety for mother and baby.

The need to keep patients satisfied and provide optimal prenatal care can be stressful. This presentation looked at a new care model that may reduce the stress while providing safe prenatal care to your patients.

Monoamniotic monochorionic twins pose a particular challenge, with a recent ACOG bulletin stating that cesarean was the safest course of delivery. This session asked whether cesarean delivery was the only option for safe delivery.

Co-testing for human papillomavirus is the recommended screening type, but some physicians may not be testing according to recent guidelines. This session compared ob/gyns to family medicine physicians to see how they stacked up and how well ob/gyns were meeting the guidelines.

Home birth can carry risks, regardless of whether the woman has previously delivered, and prior cesarean delivery can also carry risks. This session examined the risks that can occur among women who choose home birth with a history of at least one cesarean delivery.

For Contemporary OB/GYN, Dr Bobby Lazzara explains key findings from a special report published in The New England Journal of Medicine. The report looked at the teratogenic element of the Zika virus and whether causality exists.

A new study looks at whether breast density letters are too difficult for the typical woman to understand. Plus: The FDA issues a warning on fluconazole and miscarriage. Also, do irregular menses provide protection against ovarian cancer or increase risk?

Does a healthy diet reduce the risk of high blood pressure in women who had a history of gestational diabetes? Also, a new meta-analysis indicates that a way to predict preeclampsia may be possible. Plus: A look at the impact of preconception lifestyle on pregnancy loss.

Readers React

Contemporary OB/GYN readers speak up about exploratory laparotomy, the cesarean epidemic, and the difficulty to re-enter ob.

The Centers for Disease Control and Prevention have declared Zika teratogenic. Also, a look at whether the HPV vaccine is as effective in women with kidney disease. Plus: What impact does cannabis have on adverse outcomes for mom and baby?

The FDA approves the first containment system for morcellation. Plus: ASRM provides guidance for Zika virus. And, the impact of HRT timing and its impact on cardiovascular disease.

The CDC offers new guidance on Zika virus and the labor and delivery unit. Plus: How are out-of-hospital trends moving? Also, a look at whether or not planned cesareans mean poorer outcomes for children.

A study looks at how much low-level arsenic exposure impacts fetal growth. And, is there a link between intimate partner violence and adverse birth outcomes? Plus: Should all elective early-term deliveries be avoided?

Evidence on which to base management of RPL is limited, challenging ob/gyns with patients facing this stressful diagnosis.